Romosozumab

Topic
Thing
Romosozumab is a humanized monoclonal antibody that targets sclerostin for the treatment of osteoporosis. Romosozumab was originally discovered by Chiroscience, which was acquired by Celltech. Celltech entered in a partnership with Amgen in 2002 for the product's development.
Romosozumab
Definition
Romosozumab is a humanized monoclonal antibody that targets sclerostin for the treatment of osteoporosis. Romosozumab was originally discovered by Chiroscience, which was acquired by Celltech. Celltech entered in a partnership with Amgen in 2002 for the product's development.
Romosozumab
Romosozumab
Romosozumab is a humanized monoclonal antibody that targets sclerostin for the treatment of osteoporosis. Romosozumab was originally discovered by Chiroscience, which was acquired by Celltech. Celltech entered in a partnership with Amgen in 2002 for the product's development.
New to Cofactor?

Cofactor is a large, structured listing of people, places, and things. Here you can find the definition of each subject.

Your Cofactor profile
Sign up for an account to create your personal profile.